CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...
Phase 1, Phase 2
La Jolla, California, United States and 67 other locations
This research study is studying a combination of hormonal therapy, chemotherapy, and immunotherapy as a possible treatment for metastatic hormone-sen...
Phase 2
La Jolla, California, United States and 5 other locations
This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...
Phase 1
San Diego, California, United States and 18 other locations
will help in treating patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma...
Phase 1, Phase 2
La Jolla, California, United States and 2 other locations
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer age...
Phase 1, Phase 2
La Jolla, California, United States and 38 other locations
The purpose of the dose escalation phase is to evaluate the safety profile of escalating doses and dose schedules of NXP800. In the expansion phase t...
Phase 1
La Jolla, California, United States and 21 other locations
designed to examine the effects of AZD0171 and durvalumab in combination with standard-of-care chemotherapy in patients with pancreatic ductal adenocarcinoma...
Phase 2
La Jolla, California, United States and 33 other locations
The ProVent study is a randomized, open-label study designed to assess the efficacy of sipuleucel-T in reducing the progression of lower risk non-met...
Phase 3
La Jolla, California, United States and 55 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prost...
Phase 1, Phase 2
La Jolla, California, United States and 22 other locations
The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6)...
Phase 3
Tijuana, Baja California Norte, Mexico and 300 other locations
Clinical trials
Research sites
Resources
Legal